1. |
Prondzynski M, Mearini G, Carrier L. Gene therapy strategies in the treatment of hypertrophic cardiomyopathy. Pflugers Arch, 2019, 471(5): 807-815.
|
2. |
Task Force Members, Elliott PM, Anastasakis A, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J, 2014, 35(39): 2733-2779.
|
3. |
Liu LW, Zuo L, Zhou MY, et al. Efficacy and safety of transthoracic echocardiography-guided percutaneous intramyocardial septal radiofrequency ablation for the treatment of patients with obstructive hypertrophic cardiomyopathy. Chin J Cardiol, 2019, 47(4): 284-290.
|
4. |
Li W, Liu J, Huang TY, et al. Lesion outline and thermal field distribution of ablative in vitro experiments in myocardia: Comparison of radiofrequency and laser ablation. BMC Cardiovasc Disord, 2020, 20(1): 454.
|
5. |
国家心血管病中心心肌病专科联盟, 中国医疗保健国际交流促进会心血管病精准医学分会"中国成人肥厚型心肌病诊断与治疗指南2023"专家组. 中国成人肥厚型心肌病诊断与治疗指南2023. 中国循环杂志, 2023, 38(1): 1-33.The Joint Committee of Cardiomyopathy Specialty Alliance, National Center for Cardiovascular Diseases/Cardiovascular Precision Medicine Branch of China International Exchange and Promotive Association for Medical and Health Care. 2023 guideline for diagnosis and treatment of patients with hypertrophic cardiomyopathy. Chin Circ J, 2023, 38(1): 1-33.
|
6. |
Ommen SR, Mital S, Burke MA, et al. 2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: Executive summary: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 2020, 142(25): e533-e557.
|
7. |
李莹. Liwen术式治疗梗阻性肥厚型心肌病对心律失常的影响及相关影响因素. 中国人民解放军空军军医大学, 2024.LI Y. Effect of Liwen operation on arrhythmia in the treatment of obstructive hypertrophic cardiomyopathy and related influencing factors. Chinese People's Liberation Army Air Force Military Medical University, 2024.
|
8. |
Wei X. Progress in the surgical treatment of hypertrophic obstructive cardiomyopathy. J Clin Surg, 2023, 31(9): 801-803.
|
9. |
李晓艺, 吴宏祥, 王若冰, 等. 改良Morrow术治疗儿童肥厚型梗阻性心肌病远期疗效的单中心回顾性研究. 中国胸心血管外科临床杂志, 2024, 31(7): 985-990.Li XY, Wu HX, Wang RB, et al. Long-term effect of modified Morrow surgery on hypertrophic obstructive cardiomyopathy in children: A retrospective study in a single center. Chin J Clin Thorac Cardiovasc Surg, 2024, 31(7): 985-990.
|
10. |
李丹, 郗昆, 孟繁宇, 等. 老年肥厚型梗阻性心肌病患者血清肌钙蛋白Ⅰ和N末端B型利钠肽原水平及其与心脏重构的关系. 中国老年学杂志, 2020, 40(22): 4718-4720.Li D, Xi K, Meng FY, et al. Serum troponin I and N-terminal B-type natriuretic peptide levels and their relationship with cardiac remodeling in elderly patients with hypertrophic obstructive cardiomyopathy. Chin J Gerontol, 2020, 40(22): 4718-4720.
|
11. |
Falasconi G, Pannone L, Slavich M, et al. Atrial fibrillation in hypertrophic cardiomyopathy: Pathophysiology, diagnosis and management. Am J Cardiovasc Dis, 2020, 10(4): 409-418.
|
12. |
穆玉明, 南晶. 肥厚型心肌病心肌灌注与心肌力学的研究现状与进展. 中华医学超声杂志(电子版), 2020, 17(5): 391-393.Mu YM, Nan J. Research status and progress of myocardial perfusion and myocardial mechanics in hypertrophic cardiomyopathy. Chin J Med Ultrasound (Electron Ed), 2020, 17(5): 391-393.
|
13. |
Vainrib A, Massera D, Sherrid MV, et al. Three-dimensional imaging and dynamic modeling of systolic anterior motion of the mitral valve. J Am Soc Echocardiogr, 2021, 34(1): 89-96.
|